New IDF guidelines raise importance of post-meal glucose control
Acarbose therapy recommended for dysglycaemia management

Berlin / Amsterdam, October, 2007 – The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September 19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications. The new guidelines include a specific reference to acarbose (Glucobay®*) as a pharmacological agent with a substantial body of evidence proving that it lowers post-meal glucose and thereby effectively reduces the risks associated with high post-meal glucose levels.
Click here to download the press release
Click here to download the new IDF guideline

 

ESC-EASD Guidelines on Diabetes, Prediabetes and Cardiovascular Diseases

The new ESC-EASD Guidelines on Diabetes, Prediabetes and Cardiovascular Diseases were presented at the implementation meeting in Nice end of June. You can listen to all lectures of this meeting in a webcast.
more

 

International Diabetes Federation recommends Acarbose therapy for the prevention of type 2 diabetes

The International Diabetes Federation (IDF) has published a new consensus statement on type 2 diabetes prevention which recommends considering intervention with acarbose (Glucobay®) when lifestyle intervention alone has failed. The new IDF guideline was presented at the 2nd International Congress on Prediabetes and the Metabolic Syndrome held in Barcelona, Spain, April 25-28, 2007.
Download Press Release